🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this Master Protocol is to support multiple studies looking ...
Status
Not Yet Recruiting
Location
Irvine Clinical Research
Start Date
2026-09
Trial ID
NCT07787169
Treatments Being Tested
Netherton Syndrome (NS) is a severe rare disease characterized by generaliz...
Status
Terminated
Location
Saint Louis Hospital
Start Date
2023-09-28
Trial ID
NCT05979831
This is a double-blind, placebo-controlled, randomized, parallel group, two...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-06-10
Trial ID
NCT03965533
Treatments Being Tested
A randomized, double-blind, placebo-controlled phase I clinical study evalu...
Status
Not Yet Recruiting
Location
Huashan Hospital
Start Date
2025-04
Trial ID
NCT06945445
This is a Phase I/III Study to Evaluate Efficacy, Pharmacokinetics and Safe...
Status
Completed
Location
Hanyang University Medical Center
Start Date
2016-09-12
Trial ID
NCT03147248
This randomized phase III trial is studying APF530 and dexamethasone to see...
Status
Completed
Location
Anniston Oncology, PC
Start Date
2006-06
Trial ID
NCT00343460
Treatments Being Tested
Evaluate the safety and tolerability of MEDI-563 in adults with asthma and ...
Status
Completed
Location
Research Site
Start Date
2008-01
Trial ID
NCT00659659
Treatments Being Tested
This study will assess the safety, tolerability, and efficacy of ABBV-3373 ...
Status
Completed
Location
Rheum Assoc of North Alabama /ID# 213626
Start Date
2019-03-27
Trial ID
NCT03823391
Treatments Being Tested
This is a phase I study in Chinese healthy adult volunteer participants. It...
Status
Completed
Location
PKUCare Luzhong Hospital
Start Date
2025-10-14
Trial ID
NCT07466940
Treatments Being Tested
Primary Objective: To assess the safety and tolerability of GZ402668 after...
Status
Completed
Location
Investigational Site Number 276001
Start Date
2014-10
Trial ID
NCT02282826